[1]李 杰,闫 堃,杨 屹,等.Musashi1正调控肝细胞癌细胞的生长并促进其增殖[J].南方医科大学学报,2019,(12):1436-1442.[doi:10.12122/j.issn.1673-4254.2019.12.07]
 Musashi-1 positively regulates growth and proliferation of hepatoma cells in vitro[J].Journal of Southern Medical University,2019,(12):1436-1442.[doi:10.12122/j.issn.1673-4254.2019.12.07]
点击复制

Musashi1正调控肝细胞癌细胞的生长并促进其增殖()
分享到:

《南方医科大学学报》[ISSN:1673-4254/CN:44-1627/R]

卷:
期数:
2019年12期
页码:
1436-1442
栏目:
出版日期:
2020-01-01

文章信息/Info

Title:
Musashi-1 positively regulates growth and proliferation of hepatoma cells in vitro
作者:
李 杰闫 堃杨 屹李 华王志东徐 心
关键词:
肝细胞癌MSI1细胞增殖
Keywords:
hepatocellular carcinoma Musashi-1 proliferation
DOI:
10.12122/j.issn.1673-4254.2019.12.07
文献标志码:
A
摘要:
目的 Musashi1(MSI1)属于RNA结合蛋白(RBP)家族,可特异性地结合mRNA并对蛋白质的翻译起激活或抑制作用,但它在肝细胞癌(HCC)中的功能还未被深入探究。本课题主要探讨MSI1在HCC细胞生长及增殖中的作用及机制。方法 构建MSI1过表达或敲除细胞系。采用免疫组化和Western blot技术检测MSI1在HCC组织中的表达。采用MTT、流式等方法探讨过表达或沉默MSI1对HCC细胞增殖、细胞活力及细胞周期分布的影响,同时检测细胞内PCNA、Cyclin D1以及Wnt/β-catenin通路关键分子APC和β-catenin的表达。结果 MSI1在HCC组织中的表达比非肿瘤的癌旁组织高。与对照细胞相比,HepG2细胞过表达MSI1不仅显著促进了其生长(7 d时的MTT值从0.52±0.12大幅增加至1.01±0.14,P<0.01),且处于G0/G1期的细胞比率也从(58.42±3.18)%降至(40.67±1.22)%,而S期细胞比率则从(28.51±1.93)%增加至(40.06±1.92)%(P<0.01)。与此同时,细胞PCNA和Cyclin D1蛋白的表达明显上调。反之,敲除MSI1使Huh7细胞的生长显著受抑,更多细胞停滞于G0/G1期(G0/G1期细胞比率从(43.83±1.57)%增加至(62.84±1.22)%(P<0.01),同时细胞PCNA和Cyclin D1的表达则显著下调。MSI1的过表达可以降低Wnt/β-catenin信号通路分子APC但增加β-catenin的表达,反之MSI1的敲低却可以增加细胞内APC而降低β-catenin的表达。结论 MSI1可以通过正调控HCC细胞的生长及细胞周期的进程而加速HCC病程的进展,其作用可能是通过激活Wnt/β-catenin信号通路实现的。
Abstract:
Objective To investigate the regulatory role of Musashi-1 (MSI1) in the proliferation and growth of hepatocellular carcinoma (HCC) cells. Methods We examined the expression of MSI1 in HCC and paired adjacent tissues from 24 patients using immunohistochemistry and Western blotting. A MSI1-expressing vector was constructed and stably transfected into HepG2 cells, and short hairpin RNAs (shRNAs) that targeted MSI1 mRNA were ligated into the vector and stably transfected in Huh7 cells. The effects of MSI1 overexpression and silencing on the proliferation, viability and cell cycle of HepG2 cells were investigated using flow cytometry or MTT assay. The expressions of PCNA, cyclin D1, APC and β-catenin in the HCC cells were detected with Western blotting. Results MSI1 expression was significantly up-regulated in HCC tissues as compared with that in the adjacent tissues. Overexpression of MSI1 in HepG2 cells resulted in significantly enhanced cell growth (P<0.01) and significantly reduced G0/G1 phase cells from (58.42 ± 3.18)% to (40.67 ± 1.22)% and increased S phase cells from (28.51 ± 1.93)% to (40.06±1.92)% (P<0.01), causing also increases in the expressions of PCNA and Cyclin D1. Knockdown of MSI1 in Huh7 cells obviously inhibited the cell growth and caused cell cycle arrest at the G1/S phase (P<0.01) with reduced protein expressions of PCNA and cyclin D1. Overexpression of MSI1 in HepG2 cells also down-regulated the expression of APC and up-regulated the expression of β-catenin protein, while MSI1 knockdown caused reverse changes in Huh7 cells. Conclusion MSI1 promotes the progression of HCC through positive modulation of cell growth and cell cycle via the Wnt/β-catenin pathway.

相似文献/References:

[1]李湘竑,钟克波,刘延,等.索拉菲尼治疗肝癌肝移植术后肿瘤复发患者的疗效及安全性分析[J].南方医科大学学报,2011,(09):1608.
[2]郭丹,陈娜娜,侯连兵,等.前列腺素E2活化EP2受体促进肝癌细胞增殖[J].南方医科大学学报,2011,(09):1564.
[3]陈可和,梁博,邹镇洪,等.Rheb和Rheb’D60K突变基因重组慢病毒载体的构建、鉴定及其对肝癌细胞凋亡的影响[J].南方医科大学学报,2012,(03):341.
[4]赵爱国,吴曙光.沉默CDK7基因对HepG2细胞株的抗增殖作用[J].南方医科大学学报,2005,(01):58.
 ZHAO Ai-guo,WU Shu-guang.Effect of CDK7 gene silencing against hepatoblastoma HepG2 cell proliferation[J].Journal of Southern Medical University,2005,(12):58.
[5]金吴东,陈龙华,穆峰.外源性mTκα基因抑制肝癌细胞HepG2的生长[J].南方医科大学学报,2004,(10):1133.
 JIN Wu-dong,CHEN Long-hua,MU Feng.Exogenous mTκα gene inhibits the growth of HepG2 heptocellular carcinoma cells[J].Journal of Southern Medical University,2004,(12):1133.
[6]余元龙,季明芳,何洁冰,等.紫杉醇、5-氟脲嘧啶抑制肝癌细胞BEL-7402生长和诱导凋亡的比较[J].南方医科大学学报,2005,(07):864.
 YU Yuan-long,JI Ming-fang,HE Jie-bing,et al.Effects of paclitaxel and 5-fluorouracil on growth inhibition and apoptosis of hepatoma cells:a comparative study[J].Journal of Southern Medical University,2005,(12):864.
[7]陈志丰,梁宏,张祥松,等.肝癌治疗后甲胎蛋白增高患者的18F-FDG PET/CT与增强CT对照研究[J].南方医科大学学报,2012,(11):1615.
[8]李超,涂康生,郑鑫,等.MicroRNA-218在肝细胞癌中的表达及功能[J].南方医科大学学报,2013,(08):1127.
[9]黄俊海,周杰.符合Milan标准肝细胞癌患者行肝移植和肝切除术预后分析[J].南方医科大学学报,2014,(03):406.
[10]谢亮海,蒋晗,吴福生.Wnt/β-catenin信号通路在肝细胞癌中的促进作用[J].南方医科大学学报,2014,(06):913.

更新日期/Last Update: 2019-12-27